PVLA insider trading — Palvella Therapeutics, Inc.
Over the last 90 days, insiders at Palvella Therapeutics, Inc. (PVLA) made 0 open-market purchases worth $0 and 1 open-market sale worth $49K, making them net sellers by $49K. The largest sale was by Kiritsy Christopher P (Director), who sold 313 shares for $49K on Sep 2, 2026.
Updated Oct 16, 2026.
Recent PVLA insider transactions
Every Form 4 filed by Palvella Therapeutics, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 14, 2026 | Jenkins George M | Director | S · Sale · 10b5-1 | Direct | 7,174 | $123.49 | $886K | Form 4 |
| Oct 13, 2026 | Jenkins George M | Director | S · Sale · 10b5-1 | Direct | 7,174 | $130.36 | $935K | Form 4 |
| Oct 12, 2026 | Jenkins George M | Director | S · Sale · 10b5-1 | Direct | 13,152 | $133.69 | $1.76M | Form 4 |
| Sep 16, 2026 | Goin Kathleen | Chief Operating Officer | M · Option exercise · 10b5-1 | Direct | 4,302 | $8.11 | $35K | Form 4 |
| Sep 16, 2026 | Goin Kathleen | Chief Operating Officer | S · Sale · 10b5-1 | Direct | 4,302 | $152.24 | $655K | Form 4 |
| Sep 15, 2026 | Jenkins George M | Director | S · Sale · 10b5-1 | Direct | 1,777 | $150.14 | $267K | Form 4 |
| Sep 14, 2026 | Jenkins George M | Director | S · Sale · 10b5-1 | Direct | 13,352 | $151.96 | $2.03M | Form 4 |
| Sep 11, 2026 | Jenkins George M | Director | S · Sale · 10b5-1 | Direct | 12,371 | $151.28 | $1.87M | Form 4 |
| Sep 2, 2026 | Kiritsy Christopher P | Director | M · Option exercise | Direct | 313 | $127.20 | $40K | Form 4 |
| Sep 2, 2026 | Kiritsy Christopher P | Director | S · Sale | Direct | 313 | $157.00 | $49K | Form 4 |
| Aug 19, 2026 | Goin Kathleen | Chief Operating Officer | M · Option exercise · 10b5-1 | Direct | 4,302 | $8.11 | $35K | Form 4 |
| Aug 19, 2026 | Goin Kathleen | Chief Operating Officer | S · Sale · 10b5-1 | Direct | 4,302 | $152.21 | $655K | Form 4 |
PVLA insider trading FAQ
Are insiders buying PVLA stock?
Not on the open market. In the last 90 days, Palvella Therapeutics, Inc. insiders made no open-market purchases, and 1 open-market sale totaling $49K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading PVLA?
Recent sellers: Kiritsy Christopher P.
Where does PVLA insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.